Cipmolnu 200 Capsule
Marketer
Cipla Ltd
Salt Composition
Molnupiravir (200mg)
Overview Cipmolnu 200 Capsule
Molnupiravir 200mg capsules represent a pioneering oral antiviral therapy for managing mild to moderate COVID-19 in adults. Its mechanism involves inhibiting viral replication, thus lowering viral burden and disease intensity. Granted emergency authorization by Indian regulatory bodies on December 28, 2021, Molnupiravir 200mg capsules are prescribed only to adults with mild to moderate COVID-19 symptoms exhibiting a heightened risk of severe illness. Such risk factors encompass obesity, age over 60, diabetes, and cardiovascular conditions. It's contraindicated for individuals needing immediate hospitalization for COVID-19. This medication has also received emergency use approval from the U.S. FDA and the UK's equivalent regulatory agency. The recommended oral dosage is for five consecutive days; treatment should be completed regardless of symptom improvement. Potential side effects, including dizziness, headache, diarrhea, and nausea, should be reported to a physician, who can offer management strategies. Prior to commencing treatment, patients must disclose any pre-existing medical conditions and all concurrently used medications. Use is not advised during pregnancy; pregnant and lactating individuals require physician consultation before initiating this treatment.
Primary Ingredients of Cipmolnu 200 Capsule
No information provided. Please provide the text you wish me to rephrase.
Uses of Cipmolnu 200 Capsule
Managing mild to moderate cases of COVID-19
Major Benefits of Cipmolnu 200 Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Cipmolnu 200 Capsules. These capsules can be administered with or without food, though consistent timing is recommended.
Common Side effects of Cipmolnu 200 Capsule:
- Nausea
- Dizziness
- Diarrhea
How to use Cipmolnu 200 Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Cipmolnu 200 Capsules. These capsules can be taken with or without food, although consistent timing is recommended.
How Cipmolnu 200 Capsule works:
Cipmolnu 200 capsules offer antiviral action by suppressing SARS-CoV-2 replication. This mechanism prevents further viral proliferation, thereby reducing the overall viral burden within the patient.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Cipmolnu 200 Capsule's interaction with alcohol is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Cipmolnu 200 Capsules during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Lactation is contraindicated with Cipmolnu 200 Capsules due to the potential for infant toxicity.
DrivingCONSULT YOUR DOCTOR
Cipmolnu 200 Capsule's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Renal impairment does not necessitate altered dosing of Cipmolnu 200 Capsules; their use is considered safe in such patients.
LiverSAFE IF PRESCRIBED
Use of Cipmolnu 200 Capsules is considered safe for individuals with hepatic impairment. No dosage modification is necessary for Cipmolnu 200 Capsules in these patients.
What if you forget to take Cipmolnu 200 Capsule :
Omit a Cipmolnu 200 Capsule dose? Seek your physician's advice.
Facts to Know About Cipmolnu 200 Capsule
| Label | Value |
|---|---|
| Chemical Type | Cytosine-containing Nucleotides |
| Developing Habits | No. |
| Type of Treatment | Anti-infective agents |
| Active Class | Non-HIV antiviral medications |
3,018 People bought this recently